Skip navigation
home
drug products
RIBOXXIM
RIBOXXON
RIBOXXOL
key applications
technical notes
partnerships
academia
industry
public institutions
crowdfunding
about riboxx
quality management
careers
management
contact
news
Search
Riboxx : Powerful Immune Activators
Skip navigation
home
drug products
RIBOXXIM
RIBOXXON
RIBOXXOL
key applications
technical notes
partnerships
academia
industry
public institutions
crowdfunding
about riboxx
quality management
careers
management
contact
news
RIBOXX PHARMACEUTICALS and TOLLYS S.A.S announce an exclusive license agreement for treatment of Toll-like 3 positive cancers
2016-02-04 18:04
RIBOXX PHARMACEUTICALS and TOLLYS S.A.S announce an exclusive license agreement for treatment of Toll-like 3 positive cancers
Go back
Cookies faciliate the providing of our online services. By using our online services, you agree to our use of cookies.
OK
